Emergent BioSolutions
EBS
#8527
Rank
โ‚ฌ0.23 B
Marketcap
4,60ย โ‚ฌ
Share price
-1.94%
Change (1 day)
-46.31%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -4,40ย โ‚ฌ

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -4,59ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 0,87ย โ‚ฌ an increase over its 2024 EPS that were of -3,31ย โ‚ฌ.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,40ย โ‚ฌ-607.59%
20250,87ย โ‚ฌ-126.17%
2024-3,31ย โ‚ฌ-75.61%
2023-13,57ย โ‚ฌ232.21%
2022-4,08ย โ‚ฌ-203.46%
20213,95ย โ‚ฌ-25.09%
20205,27ย โ‚ฌ445.28%
20190,97ย โ‚ฌ-15.2%
20181,14ย โ‚ฌ-35.9%
20171,78ย โ‚ฌ69.57%
20161,05ย โ‚ฌ-27.67%
20151,45ย โ‚ฌ65.62%
20140,88ย โ‚ฌ11.63%
20130,78ย โ‚ฌ32.31%
20120,59ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,65ย โ‚ฌ-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,91ย โ‚ฌ-119.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,62ย โ‚ฌ-157.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-1,64ย โ‚ฌ-64.29%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
0,48ย โ‚ฌ-110.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,97ย โ‚ฌ-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,41ย โ‚ฌ-108.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel